Cargando…

Predicting the outcome of COVID-19 infection in kidney transplant recipients

BACKGROUND: We aimed to present the demographic characteristics, clinical presentation, and outcomes of our multicenter cohort of adult KTx recipients with COVID-19. METHODS: We conducted a multicenter, retrospective study using data of patients hospitalized for COVID-19 collected from 34 centers in...

Descripción completa

Detalles Bibliográficos
Autores principales: Oto, Ozgur Akin, Ozturk, Savas, Turgutalp, Kenan, Arici, Mustafa, Alpay, Nadir, Merhametsiz, Ozgur, Sipahi, Savas, Ogutmen, Melike Betul, Yelken, Berna, Altiparmak, Mehmet Riza, Gorgulu, Numan, Tatar, Erhan, Ozkan, Oktay, Ayar, Yavuz, Aydin, Zeki, Dheir, Hamad, Ozkok, Abdullah, Safak, Seda, Demir, Mehmet Emin, Odabas, Ali Riza, Tokgoz, Bulent, Tonbul, Halil Zeki, Sezer, Siren, Ates, Kenan, Yildiz, Alaattin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977489/
https://www.ncbi.nlm.nih.gov/pubmed/33740915
http://dx.doi.org/10.1186/s12882-021-02299-w
_version_ 1783667123647676416
author Oto, Ozgur Akin
Ozturk, Savas
Turgutalp, Kenan
Arici, Mustafa
Alpay, Nadir
Merhametsiz, Ozgur
Sipahi, Savas
Ogutmen, Melike Betul
Yelken, Berna
Altiparmak, Mehmet Riza
Gorgulu, Numan
Tatar, Erhan
Ozkan, Oktay
Ayar, Yavuz
Aydin, Zeki
Dheir, Hamad
Ozkok, Abdullah
Safak, Seda
Demir, Mehmet Emin
Odabas, Ali Riza
Tokgoz, Bulent
Tonbul, Halil Zeki
Sezer, Siren
Ates, Kenan
Yildiz, Alaattin
author_facet Oto, Ozgur Akin
Ozturk, Savas
Turgutalp, Kenan
Arici, Mustafa
Alpay, Nadir
Merhametsiz, Ozgur
Sipahi, Savas
Ogutmen, Melike Betul
Yelken, Berna
Altiparmak, Mehmet Riza
Gorgulu, Numan
Tatar, Erhan
Ozkan, Oktay
Ayar, Yavuz
Aydin, Zeki
Dheir, Hamad
Ozkok, Abdullah
Safak, Seda
Demir, Mehmet Emin
Odabas, Ali Riza
Tokgoz, Bulent
Tonbul, Halil Zeki
Sezer, Siren
Ates, Kenan
Yildiz, Alaattin
author_sort Oto, Ozgur Akin
collection PubMed
description BACKGROUND: We aimed to present the demographic characteristics, clinical presentation, and outcomes of our multicenter cohort of adult KTx recipients with COVID-19. METHODS: We conducted a multicenter, retrospective study using data of patients hospitalized for COVID-19 collected from 34 centers in Turkey. Demographic characteristics, clinical findings, laboratory parameters (hemogram, CRP, AST, ALT, LDH, and ferritin) at admission and follow-up, and treatment strategies were reviewed. Predictors of poor clinical outcomes were analyzed. The primary outcomes were in-hospital mortality and the need for ICU admission. The secondary outcome was composite in-hospital mortality and/or ICU admission. RESULTS: One hundred nine patients (male/female: 63/46, mean age: 48.4 ± 12.4 years) were included in the study. Acute kidney injury (AKI) developed in 46 (42.2%) patients, and 4 (3.7%) of the patients required renal replacement therapy (RRT). A total of 22 (20.2%) patients were admitted in the ICU, and 19 (17.4%) patients required invasive mechanical ventilation. 14 (12.8%) of the patients died. Patients who were admitted in the ICU were significantly older (age over 60 years) (38.1% vs 14.9%, p = 0.016). 23 (21.1%) patients reached to composite outcome and these patients were significantly older (age over 60 years) (39.1% vs. 13.9%; p = 0.004), and had lower serum albumin (3.4 g/dl [2.9–3.8] vs. 3.8 g/dl [3.5–4.1], p = 0.002), higher serum ferritin (679 μg/L [184–2260] vs. 331 μg/L [128–839], p = 0.048), and lower lymphocyte counts (700/μl [460–950] vs. 860 /μl [545–1385], p = 0.018). Multivariable analysis identified presence of ischemic heart disease and initial serum creatinine levels as independent risk factors for mortality, whereas age over 60 years and initial serum creatinine levels were independently associated with ICU admission. On analysis for predicting secondary outcome, age above 60 and initial lymphocyte count were found to be independent variables in multivariable analysis. CONCLUSION: Over the age of 60, ischemic heart disease, lymphopenia, poor graft function were independent risk factors for severe COVID-19 in this patient group. Whereas presence of ischemic heart disease and poor graft function were independently associated with mortality.
format Online
Article
Text
id pubmed-7977489
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79774892021-03-19 Predicting the outcome of COVID-19 infection in kidney transplant recipients Oto, Ozgur Akin Ozturk, Savas Turgutalp, Kenan Arici, Mustafa Alpay, Nadir Merhametsiz, Ozgur Sipahi, Savas Ogutmen, Melike Betul Yelken, Berna Altiparmak, Mehmet Riza Gorgulu, Numan Tatar, Erhan Ozkan, Oktay Ayar, Yavuz Aydin, Zeki Dheir, Hamad Ozkok, Abdullah Safak, Seda Demir, Mehmet Emin Odabas, Ali Riza Tokgoz, Bulent Tonbul, Halil Zeki Sezer, Siren Ates, Kenan Yildiz, Alaattin BMC Nephrol Research Article BACKGROUND: We aimed to present the demographic characteristics, clinical presentation, and outcomes of our multicenter cohort of adult KTx recipients with COVID-19. METHODS: We conducted a multicenter, retrospective study using data of patients hospitalized for COVID-19 collected from 34 centers in Turkey. Demographic characteristics, clinical findings, laboratory parameters (hemogram, CRP, AST, ALT, LDH, and ferritin) at admission and follow-up, and treatment strategies were reviewed. Predictors of poor clinical outcomes were analyzed. The primary outcomes were in-hospital mortality and the need for ICU admission. The secondary outcome was composite in-hospital mortality and/or ICU admission. RESULTS: One hundred nine patients (male/female: 63/46, mean age: 48.4 ± 12.4 years) were included in the study. Acute kidney injury (AKI) developed in 46 (42.2%) patients, and 4 (3.7%) of the patients required renal replacement therapy (RRT). A total of 22 (20.2%) patients were admitted in the ICU, and 19 (17.4%) patients required invasive mechanical ventilation. 14 (12.8%) of the patients died. Patients who were admitted in the ICU were significantly older (age over 60 years) (38.1% vs 14.9%, p = 0.016). 23 (21.1%) patients reached to composite outcome and these patients were significantly older (age over 60 years) (39.1% vs. 13.9%; p = 0.004), and had lower serum albumin (3.4 g/dl [2.9–3.8] vs. 3.8 g/dl [3.5–4.1], p = 0.002), higher serum ferritin (679 μg/L [184–2260] vs. 331 μg/L [128–839], p = 0.048), and lower lymphocyte counts (700/μl [460–950] vs. 860 /μl [545–1385], p = 0.018). Multivariable analysis identified presence of ischemic heart disease and initial serum creatinine levels as independent risk factors for mortality, whereas age over 60 years and initial serum creatinine levels were independently associated with ICU admission. On analysis for predicting secondary outcome, age above 60 and initial lymphocyte count were found to be independent variables in multivariable analysis. CONCLUSION: Over the age of 60, ischemic heart disease, lymphopenia, poor graft function were independent risk factors for severe COVID-19 in this patient group. Whereas presence of ischemic heart disease and poor graft function were independently associated with mortality. BioMed Central 2021-03-19 /pmc/articles/PMC7977489/ /pubmed/33740915 http://dx.doi.org/10.1186/s12882-021-02299-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Oto, Ozgur Akin
Ozturk, Savas
Turgutalp, Kenan
Arici, Mustafa
Alpay, Nadir
Merhametsiz, Ozgur
Sipahi, Savas
Ogutmen, Melike Betul
Yelken, Berna
Altiparmak, Mehmet Riza
Gorgulu, Numan
Tatar, Erhan
Ozkan, Oktay
Ayar, Yavuz
Aydin, Zeki
Dheir, Hamad
Ozkok, Abdullah
Safak, Seda
Demir, Mehmet Emin
Odabas, Ali Riza
Tokgoz, Bulent
Tonbul, Halil Zeki
Sezer, Siren
Ates, Kenan
Yildiz, Alaattin
Predicting the outcome of COVID-19 infection in kidney transplant recipients
title Predicting the outcome of COVID-19 infection in kidney transplant recipients
title_full Predicting the outcome of COVID-19 infection in kidney transplant recipients
title_fullStr Predicting the outcome of COVID-19 infection in kidney transplant recipients
title_full_unstemmed Predicting the outcome of COVID-19 infection in kidney transplant recipients
title_short Predicting the outcome of COVID-19 infection in kidney transplant recipients
title_sort predicting the outcome of covid-19 infection in kidney transplant recipients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977489/
https://www.ncbi.nlm.nih.gov/pubmed/33740915
http://dx.doi.org/10.1186/s12882-021-02299-w
work_keys_str_mv AT otoozgurakin predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT ozturksavas predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT turgutalpkenan predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT aricimustafa predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT alpaynadir predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT merhametsizozgur predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT sipahisavas predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT ogutmenmelikebetul predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT yelkenberna predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT altiparmakmehmetriza predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT gorgulunuman predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT tatarerhan predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT ozkanoktay predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT ayaryavuz predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT aydinzeki predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT dheirhamad predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT ozkokabdullah predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT safakseda predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT demirmehmetemin predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT odabasaliriza predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT tokgozbulent predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT tonbulhalilzeki predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT sezersiren predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT ateskenan predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients
AT yildizalaattin predictingtheoutcomeofcovid19infectioninkidneytransplantrecipients